AYTU BIOPHARMA, INC — Director's Dealing 2016

Jul 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-07-07

Reporting Person: McGrael Jonathan H (VP of Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-07	Common Stock	A	140000	$0.00	Acquired	140000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-07	Employee Stock Option Grant	$18.12	D	16667	Disposed	2025-11-11	Common Stock (16667)	Direct
2016-07-07	Employee Stock Option Grant	$3.23	A	16667	Acquired	2025-11-11	Common Stock (16667)	Direct
2016-07-07	Employee Stock Option Grant	$3.23	A	23333	Acquired	2026-07-07	Common Stock (23333)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option Grant	$18.12	2025-11-11	Common Stock (16667)	16667	Direct

Footnotes

F1: These are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.

F2: The number of shares has been decreased and the exercise price has been increased to reflect the twelve-for-one stock split effected on June 30, 2016.

F3: 33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates.

F4: These two transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option.

F5: 33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.